GSK and Immunovaccine: delivery techs promise to deliver Ebola vaccine
A candidate Ebola vaccine that uses Immunovaccine's formulation technology has stopped cynomolgus monkeys from catching the disease in a preclinical study.
A candidate Ebola vaccine that uses Immunovaccine's formulation technology has stopped cynomolgus monkeys from catching the disease in a preclinical study.
Novo Nordisk has bought a biomanufacturing facility earmarked for closure by Olympus Biotech and begun rehiring staff in order to support its haemophilia product pipeline.
Acquisitions in the single-use tech space helped drive growth in fiscal 2014 according to Pall, which plans to continue its two-pronged M&A strategy.